The prognostic significance of sarcopenia in patients treated with definitive radiotherapy: A systematic review
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818
Muscaritoli, M., Anker, S. D., Argilés, J., Aversa, Z., Bauer, J. M., Biolo, G., Boirie, Y., Bosaeus, I., Cederholm, T., Costelli, P., et al. (2010) · Clinical Nutrition · doi:10.1016/j.clnu.2009.12.004 · Cited by 1,732
Shen, W., Punyanitya, M., Wang, Z., Gallagher, D., St.-Onge, M.-P., Albu, J., Heymsfield, S. B., & Heshka, S. (2004) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00744.2004 · Cited by 1,692
Sarcopenia as a risk factor for falls in elderly individuals: results from the ilSIRENTE study
Landi, F., Liperoti, R., Russo, A., Giovannini, S., Tosato, M., Capoluongo, E., Bernabei, R., & Onder, G. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2012.02.007 · Cited by 938
Impact of Sarcopenia on Outcomes Following Resection of Pancreatic Adenocarcinoma
Peng, P., Hyder, O., Firoozmand, A., Kneuertz, P., Schulick, R. D., Huang, D., Makary, M., Hirose, K., Edil, B., Choti, M. A., et al. (2012) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-012-1923-5 · Cited by 546
McGregor, R. A., Cameron-Smith, D., & Poppitt, S. D. (2014) · Longevity & Healthspan · doi:10.1186/2046-2395-3-9 · Cited by 532
Derstine, B. A., Holcombe, S. A., Ross, B. E., Wang, N. C., Su, G. L., & Wang, S. C. (2018) · Scientific Reports · doi:10.1038/s41598-018-29825-5 · Cited by 507
Baracos, V. E., & Arribas, L. (2018) · Annals of Oncology · doi:10.1093/annonc/mdx810 · Cited by 362
Kim, Y.-S., Lee, Y., Chung, Y.-S., Lee, D.-J., Joo, N.-S., Hong, D., Song, G. E., Kim, H.-J., Choi, Y. J., & Kim, K.-M. (2012) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/gls071 · Cited by 327
Kyle, U. G., Genton, L., Hans, D., & Pichard, C. (2003) · Clinical Nutrition · doi:10.1016/s0261-5614(03)00048-7 · Cited by 248
Akune, T., Muraki, S., Oka, H., Tanaka, S., Kawaguchi, H., Tokimura, F., Yoshida, H., Suzuki, T., Nakamura, K., & Yoshimura, N. (2014) · Geriatrics & Gerontology International · doi:10.1111/ggi.12155 · Cited by 91
Research works printed but not linked: 99
- Shachar, 2016, Prognostic value of sarcopenia in adults with solid tumours: a meta-analysis and systematic review, Eur J Can, 57, 58, 10.1016/j.ejca.2015.12.030 · DOI · Paper page
- Keller, 2013, Strength and muscle mass loss with aging process. Age and strength loss, Muscles Ligaments Tendons J, 3, 346, 10.32098/mltj.04.2013.17 · DOI · Paper page
- Joseph, 2005, Role of endocrine-immune dysregulation in osteoporosis, sarcopenia, frailty and fracture risk, Mol Aspects Med, 26, 181, 10.1016/j.mam.2005.01.004 · DOI
- Bahat, 2016, Sarcopenia and the cardiometabolic syndrome: a narrative review, Eur Geriatric Med, 7, 220, 10.1016/j.eurger.2015.12.012 · DOI
- Bone, 2017, Sarcopenia and frailty in chronic respiratory disease, Chron Respir Dis, 14, 85, 10.1177/1479972316679664 · DOI · Paper page
- Beaudart, 2017, Validation of the SarQoL®, a specific health-related quality of life questionnaire for Sarcopenia, J Cachexia Sarcopenia Muscle, 8, 238, 10.1002/jcsm.12149 · DOI · Paper page
- Landi, 2013, Sarcopenia and mortality risk in frail older persons aged 80 years and older: results from ilSIRENTE study, Age Ageing, 42, 203, 10.1093/ageing/afs194 · DOI · Paper page
- Sousa, 2016, Sarcopenia and length of hospital stay, Eur J Clin Nutr, 70, 595, 10.1038/ejcn.2015.207 · DOI · Paper page
- Antunes, 2017, Sarcopenia and hospitalisation costs in older adults: a cross-sectional study, Nutr Diet, 74, 46, 10.1111/1747-0080.12287 · DOI · Paper page
- Beaudart, 2016, Sarcopenia in daily practice: assessment and management, BMC Geriatr, 16, 170, 10.1186/s12877-016-0349-4 · DOI · Paper page
- Chu, 2015, Fully automatic localization and segmentation of 3D vertebral bodies from CT/MR images via a learning-based method, PLoS One, 10, 10.1371/journal.pone.0143327 · DOI
- Bozzetti, 2017, Forcing the vicious circle: sarcopenia increases toxicity, decreases response to chemotherapy and worsens with chemotherapy, Ann Oncol, 28, 2107, 10.1093/annonc/mdx271 · DOI · Paper page
- Trejo-Avila, 2021, Sarcopenia predicts worse postoperative outcomes and decreased survival rates in patients with colorectal cancer: a systematic review and meta-analysis, Int J Colorectal Dis, 36, 1077, 10.1007/s00384-021-03839-4 · DOI · Paper page
- Baskar, 2012, Cancer and radiation therapy: current advances and future directions, Int J Med Sci, 9, 193, 10.7150/ijms.3635 · DOI · Paper page
- Di Maggio, 2015, Portrait of inflammatory response to ionizing radiation treatment, J Inflamm, 12, 14, 10.1186/s12950-015-0058-3 · DOI · Paper page
- Cho, 2018, Prognostic significance of sarcopenia with inflammation in patients with head and neck cancer who underwent definitive chemoradiotherapy, Front Oncol, 8, 457, 10.3389/fonc.2018.00457 · DOI
- Nagpal, 2021, Impact of sarcopenia in locally advanced head and neck cancer treated with chemoradiation: an Indian tertiary care hospital experience, Oral Oncol, 121, 10.1016/j.oraloncology.2021.105483 · DOI
- Shodo, 2021, Sarcopenia predicts a poor treatment outcome in patients with head and neck squamous cell carcinoma receiving concurrent chemoradiotherapy, Eur Arch Otorhinolaryngol, 278, 2001, 10.1007/s00405-020-06273-4 · DOI
- Bergamaschi, 2023, Prognostic impact of sarcopenia's occurrence during radiotherapy in oropharyngeal cancer patients, Cancers (Basel), 15, 10.3390/cancers15030723 · DOI · Paper page
- Wendrich, 2017, Low skeletal muscle mass is a predictive factor for chemotherapy dose-limiting toxicity in patients with locally advanced head and neck cancer, Oral Oncol, 71, 26, 10.1016/j.oraloncology.2017.05.012 · DOI · Paper page
- Pai, 2018, Pretreatment subcutaneous adipose tissue predicts the outcomes of patients with head and neck cancer receiving definitive radiation and chemoradiation in Taiwan, Cancer Med, 7, 1630, 10.1002/cam4.1365 · DOI
- Hua, 2021, Modeling sarcopenia to predict survival for patients with nasopharyngeal carcinoma receiving concurrent chemoradiotherapy, Front Oncol, 11, 10.3389/fonc.2021.625534 · doi:10.3389/fonc.2021.625534
- Sato, 2018, Impact of sarcopenia in patients with unresectable locally advanced esophageal cancer receiving chemoradiotherapy, In Vivo, 32, 603
- Ma, 2019, Relationship Between Sarcopenia and Prognosis in Patient With Concurrent Chemo-Radiation Therapy for Esophageal Cancer, Front Oncol, 9, 366, 10.3389/fonc.2019.00366 · DOI
- Mallet, 2020, Prognostic value of sarcopenia in patients treated by Radiochemotherapy for locally advanced oesophageal cancer, Radiat Oncol, 15, 116, 10.1186/s13014-020-01545-z · DOI
- Liang, 2021, Prognostic value of sarcopenia and systemic inflammation markers in patients undergoing definitive radiotherapy for esophageal cancer, Cancer Manag Res, 13, 181, 10.2147/CMAR.S288522 · DOI
- Qian, 2022, Sarcopenia is associated with prognosis in patients with esophageal squamous cell cancer after radiotherapy or chemoradiotherapy, BMC Gastroenterol, 22, 211, 10.1186/s12876-022-02296-9 · DOI
- McSweeney, 2023, Low muscle mass measured at T12 is a prognostic biomarker in unresectable oesophageal cancers receiving chemoradiotherapy, Radiother Oncol, 186, 10.1016/j.radonc.2023.109764 · DOI
- Shiba, 2018, No Deterioration in clinical outcomes of carbon ion radiotherapy for sarcopenia patients with hepatocellular carcinoma, Anticancer Res, 38, 3579, 10.21873/anticanres.12631 · doi:10.21873/anticanres.12631
- Jin, 2018, Impact of sarcopenia in borderline resectable and locally advanced pancreatic cancer patients receiving stereotactic body radiation therapy, J Gastrointest Oncol, 9, 24, 10.21037/jgo.2017.09.13 · DOI
- Cho, 2021, Impact of sarcopenia on survival of pancreatic cancer patients treated with concurrent chemoradiotherapy, Tumori, 107, 247, 10.1177/0300891620937795 · DOI
- Martin, 2020, Sarcopenia is associated with hematologic toxicity during chemoradiotherapy in patients with anal carcinoma, Front Oncol, 10, 1576, 10.3389/fonc.2020.01576 · DOI
- Katsui, 2021, Sarcopenia is associated with poor prognosis after chemoradiotherapy in patients with stage III non-small-cell lung cancer: a retrospective analysis, Sci Rep, 11, 11882, 10.1038/s41598-021-91449-z · DOI
- Kiss, 2019, Early skeletal muscle loss in non-small cell lung cancer patients receiving chemoradiation and relationship to survival, Support Care Can, 27, 2657, 10.1007/s00520-018-4563-9 · DOI
- Matsuo, 2018, Impact of low skeletal muscle mass on non-lung cancer mortality after stereotactic body radiotherapy for patients with stage I non-small cell lung cancer, J Geriatr Oncol, 9, 589, 10.1016/j.jgo.2018.05.003 · DOI
- Mitsuyoshi, 2018, Evaluation of a prognostic scoring system based on the systemic inflammatory and nutritional status of patients with locally advanced non-small-cell lung cancer treated with chemoradiotherapy, J Radiat Res, 59, 50, 10.1093/jrr/rrx060 · DOI
- Stangl-Kremser, 2019, Prognostic value of nutritional indices and body composition parameters including sarcopenia in patients treated with radiotherapy for urothelial carcinoma of the bladder, Urol Oncol, 37, 372, 10.1016/j.urolonc.2018.11.001 · DOI
- Ferini, 2021, Curative Radiotherapy in Elderly Patients With Muscle Invasive Bladder Cancer: The Prognostic Role of Sarcopenia, In Vivo, 35, 571, 10.21873/invivo.12293 · DOI
- McDonald, 2017, CT measures of bone mineral density and muscle mass can be used to predict noncancer death in men with prostate cancer, Radiology, 282, 475, 10.1148/radiol.2016160626 · DOI
- Matsuoka, 2019, Sarcopenia is not a prognostic factor of outcome in patients with cervical cancer undergoing concurrent chemoradiotherapy or radiotherapy, Anticancer Res, 39, 933, 10.21873/anticanres.13196 · DOI
- Lee, 2018, Skeletal muscle loss is an imaging biomarker of outcome after definitive chemoradiotherapy for locally advanced cervical cancer, Clin Can Res, 24, 5028, 10.1158/1078-0432.CCR-18-0788 · DOI
- Klinder, 2009, Automated model-based vertebra detection, identification, and segmentation in CT images, Med Image Anal, 13, 471, 10.1016/j.media.2009.02.004 · DOI · Paper page
- Forsberg, 2017, Detection and labeling of vertebrae in MR images using deep learning with clinical annotations as training data, J Digit Imaging, 30, 406, 10.1007/s10278-017-9945-x · DOI
- Mourtzakis, 2008, A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care, Appl Physiol Nutr Metab, 33, 997, 10.1139/H08-075 · DOI · Paper page
- Anyene, 2022, Body composition from single versus multi-slice abdominal computed tomography: concordance and associations with colorectal cancer survival, J Cachexia Sarcopenia Muscle, 13, 2974, 10.1002/jcsm.13080 · DOI
- Panthofer, 2019, Derivation and validation of thoracic sarcopenia assessment in patients undergoing thoracic endovascular aortic repair, J Vasc Surg, 69, 1379, 10.1016/j.jvs.2018.08.180 · DOI
- Swartz, 2016, Feasibility of using head and neck CT imaging to assess skeletal muscle mass in head and neck cancer patients, Oral Oncol, 62, 28, 10.1016/j.oraloncology.2016.09.006 · DOI · Paper page
- Chang, 2021, Masticatory muscle index for indicating skeletal muscle mass in patients with head and neck cancer, PLoS One, 16
- Yoon, 2021, Skeletal muscle mass at C3 may not be a strong predictor for skeletal muscle mass at L3 in sarcopenic patients with head and neck cancer, PLoS One, 16, 10.1371/journal.pone.0254844 · DOI
- Gu, 2018, Clinical usefulness of psoas muscle thickness for the diagnosis of sarcopenia in patients with liver cirrhosis, Clin Mol Hepatol, 24, 319, 10.3350/cmh.2017.0077 · DOI · Paper page
- Rutten, 2017, Psoas muscle area is not representative of total skeletal muscle area in the assessment of sarcopenia in ovarian cancer, J Cachexia Sarcopenia Muscle, 8, 630, 10.1002/jcsm.12180 · DOI · Paper page
- Sebro, 2016, Assessment of trunk muscle density using CT and its association with degenerative disc and facet joint disease of the lumbar spine, Skeletal Radiol, 45, 1221, 10.1007/s00256-016-2405-8 · DOI
- Prado, 2008, Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study, Lancet Oncol, 9, 629, 10.1016/S1470-2045(08)70153-0 · DOI · Paper page
- Martin, 2013, Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index, J Clin Oncol, 31, 1539, 10.1200/JCO.2012.45.2722 · DOI · Paper page
- Silva, 2010, Ethnicity-related skeletal muscle differences across the lifespan, Am J Hum Biol, 22, 76, 10.1002/ajhb.20956 · DOI · Paper page
- Heagerty, 2000, Time-dependent ROC curves for censored survival data and a diagnostic marker, Biometrics, 56, 337, 10.1111/j.0006-341X.2000.00337.x · DOI · Paper page
- van Vledder, 2012, Body composition and outcome in patients undergoing resection of colorectal liver metastases19, Br J Surg, 99, 550, 10.1002/bjs.7823 · DOI · Paper page
- Fujiwara, 2015, Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma, J Hepatol, 63, 131, 10.1016/j.jhep.2015.02.031 · DOI · Paper page
- Janssen, 2000, Skeletal muscle mass and distribution in 468 men and women aged 18-88 yr, J Appl Physiol, 89, 81, 10.1152/jappl.2000.89.1.81 · DOI · Paper page
- Erul, 2023, Role of sarcopenia on survival and treatment-related toxicity in head and neck cancer: a narrative review of current evidence and future perspectives, Eur Arch Otorhinolaryngol, 280, 3541, 10.1007/s00405-023-08014-9 · DOI
- de Bree, 2022, Sarcopenia and its impact in head and neck cancer treatment, Curr Opin Otolaryngol Head Neck Surg, 30, 87, 10.1097/MOO.0000000000000792 · DOI
- Findlay, 2020, The association between computed tomography-defined sarcopenia and outcomes in adult patients undergoing radiotherapy of curative intent for headand neck cancer: a systematic review, J Acad Nutr Diet, 120, 10.1016/j.jand.2020.03.021 · DOI
- Hua, 2019, When the loss costs too much: a systematic review and meta-analysis of sarcopenia in head and neck cancer, Front Oncol, 9, 1561, 10.3389/fonc.2019.01561 · DOI
- Medici, 2022, Impact and treatment of sarcopenia in patients undergoing radiotherapy: a multidisciplinary, AMSTAR-2 compliant review of systematic reviews and metanalyses, Front Oncol, 12, 10.3389/fonc.2022.887156 · DOI
- Paireder, 2017, Impact of sarcopenia on outcome in patients with esophageal resection following neoadjuvant chemotherapy for esophageal cancer, Eur J Surg Oncol, 43, 478, 10.1016/j.ejso.2016.11.015 · DOI
- Grotenhuis, 2016, Sarcopenia/muscle mass is not a prognostic factor for short- and long-term outcome after esophagectomy for cancer, World J Surg, 40, 2698, 10.1007/s00268-016-3603-1 · DOI · Paper page
- Jogiat, 2022, Sarcopenia reduces overall survival in unresectable oesophageal cancer: a systematic review and meta-analysis, J Cachexia Sarcopenia Muscle, 13, 2630, 10.1002/jcsm.13082 · DOI
- Harimoto, 2013, Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma, Br J Surg, 100, 1523, 10.1002/bjs.9258 · DOI · Paper page
- Mintziras, 2018, Sarcopenia and sarcopenic obesity are significantly associated with poorer overall survival in patients with pancreatic cancer: systematic review and meta-analysis, Int J Surg, 59, 19, 10.1016/j.ijsu.2018.09.014 · DOI · Paper page
- Buentzel, 2019, Sarcopenia as prognostic factor in lung cancer patients: a systematic review and meta-analysis, Anticancer Res, 39, 4603, 10.21873/anticanres.13640 · DOI
- Yang, 2019, Prognostic value of sarcopenia in lung cancer: a systematic review and meta-analysis, Chest, 156, 101, 10.1016/j.chest.2019.04.115 · DOI · Paper page
- Bingmer, 2020, Sarcopenia is associated with worse overall survival in patients with anal squamous cell cancer, J Surg Oncol, 121, 1148, 10.1002/jso.25887 · DOI
- De Nardi, 2022, Relation between skeletal muscle volume and prognosis in rectal cancer patients undergoing neoadjuvant therapy, World J Gastrointest Oncol, 14, 423, 10.4251/wjgo.v14.i2.423 · DOI
- Vergara-Fernandez, 2020, Sarcopenia in patients with colorectal cancer: a comprehensive review, World J Clin Cases, 8, 1188, 10.12998/wjcc.v8.i7.1188 · DOI
- Psutka, 2014, Sarcopenia in patients with bladder cancer undergoing radical cystectomy: impact on cancer-specific and all-cause mortality, Cancer, 120, 2910, 10.1002/cncr.28798 · DOI · Paper page
- Catikkas, 2022, Older cancer patients receiving radiotherapy: a systematic review for the role of sarcopenia in treatment outcomes, Aging Clin Exp Res, 34, 1747, 10.1007/s40520-022-02085-0 · DOI
- Chargi, 2019, Sarcopenia is a prognostic factor for overall survival in elderly patients with head-and-neck cancer, Eur Arch Otorhinolaryngol, 276, 1475, 10.1007/s00405-019-05361-4 · DOI
- Jahrreiss, 2021, The prognostic value of sarcopenia in patients with prostate cancer: a systematic review, Curr Opin Urol, 31, 10.1097/MOU.0000000000000885 · DOI
- Zakaria, 2020, Sarcopenia predicts overall survival in patients with lung, breast, prostate, or myeloma spine metastases undergoing stereotactic body radiation therapy (SBRT), Independent of Histology Neurosurgery, 86, 705
- Gadducci, 2021, The prognostic relevance of computed tomography-assessed skeletal muscle index and skeletal muscle radiation attenuation in patients with gynecological cancer, Anticancer Res, 41, 9, 10.21873/anticanres.14747 · DOI
- Xiao, 2024, Impact of skeletal muscle loss and sarcopenia on outcomes of locally advanced esophageal cancer during neoadjuvant chemoradiation, Ann Surg Oncol
- Abe, 2022, Preoperative sarcopenia is a poor prognostic factor in lower rectal cancer patients undergoing neoadjuvant chemoradiotherapy: a retrospective study, Int J Clin Oncol, 27, 141, 10.1007/s10147-021-02062-z · DOI
- Ming, 2023, Prognostic impact of sarcopenia in patients with locally advanced adenocarcinoma of the esophagogastric junction treated with neoadjuvant chemoradiotherapy, Front Nutrit, 10
- Grossberg, 2021, Bioelectrical impedance analysis as a quantitative measure of sarcopenia in head and neck cancer patients treated with radiotherapy, Radiother Oncol, 159, 21, 10.1016/j.radonc.2021.03.005 · DOI
- Grossberg, 2016, Association of body composition with survival and locoregional control of radiotherapy-treated head and neck squamous cell carcinoma, JAMA Oncol, 2, 782, 10.1001/jamaoncol.2015.6339 · DOI · Paper page
- Findlay, 2020, Sarcopenia and myosteatosis in patients undergoing curative radiotherapy for head and neck cancer: Impact on survival, treatment completion, hospital admission and cost, J Hum Nutr Diet, 33, 811, 10.1111/jhn.12788 · DOI
- Yoon, 2020, Prognostic impact of sarcopenia and skeletal muscle loss during neoadjuvant chemoradiotherapy in esophageal cancer, Cancers (Basel), 12, 10.3390/cancers12040925 · DOI
- Sanchez A, Perni S, Kim P, Horowitz DP. Surgical resection after neoadjuvant chemoradiation in patients with sarcopenia and pancreatic cancer. Int J Radiat Oncol Biol Phys 2019;105(1, Supplement):E244-E5. · doi:10.1016/j.ijrobp.2019.06.1927
- Aleixo, 2020, Myosteatosis and prognosis in cancer: systematic review and meta-analysis, Crit Rev Oncol Hematol, 145, 10.1016/j.critrevonc.2019.102839 · DOI · Paper page
- Stenholm, 2008, Sarcopenic obesity: definition, cause and consequences, Curr Opin Clin Nutr Metab Care, 11, 693, 10.1097/MCO.0b013e328312c37d · DOI · Paper page
- Huo, 2024, Grip-Strength-Lean-Mass Index (GSLMI) as a valuable tool for sarcopenia diagnosis and survival prognosis in cancer patients: a nationwide multicenter cohort study, J Nutr Health Aging, 29
- Davis, 2019, Sarcopenia associated with chemotherapy and targeted agents for cancer therapy, Ann Palliat Med, 8, 86, 10.21037/apm.2018.08.02 · DOI · Paper page
- Greten, 2019, Inflammation and cancer: triggers, mechanisms, and consequences, Immunity, 51, 27, 10.1016/j.immuni.2019.06.025 · DOI · Paper page
- Capitão, 2022, Protein intake and muscle mass maintenance in patients with cancer types with high prevalence of sarcopenia: a systematic review, Support Care Cancer, 30, 3007, 10.1007/s00520-021-06633-8 · DOI
- Prokopidis, 2022, Effect of vitamin D monotherapy on indices of sarcopenia in community-dwelling older adults: a systematic review and meta-analysis, J Cachexia Sarcopenia Muscle, 13, 1642, 10.1002/jcsm.12976 · DOI · Paper page
- Read, 2007, Nutrition intervention using an eicosapentaenoic acid (EPA)-containing supplement in patients with advanced colorectal cancer. Effects on nutritional and inflammatory status: a phase II trial, Support Care Cancer, 15, 301, 10.1007/s00520-006-0153-3 · DOI
- Wright, 2018, A randomized trial of adjunct testosterone for cancer-related muscle loss in men and women, J Cachexia Sarcopenia Muscle, 9, 482, 10.1002/jcsm.12295 · DOI · Paper page
- Adams, 2016, Impact of resistance and aerobic exercise on sarcopenia and dynapenia in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial, Breast Cancer Res Treat, 158, 497, 10.1007/s10549-016-3900-2 · DOI · Paper page
- Sharp, 2014, The effects of a myostatin inhibitor on lean body mass, strength, and power in resistance trained males, J Int Soc Sports Nutr, 11, P42, 10.1186/1550-2783-11-S1-P42 · DOI
Metadata
- Authors
- Vickers, A. J., McSweeney, D. M., Choudhury, A., Weaver, J., Price, G., & McWilliam, A.
- Venue
- Radiotherapy and Oncology
- Publisher
- Elsevier BV
- Published
- 2025-02
- Volume
- 203
- Pages
- 110663
- ISSN
- 0167-8140
- Cited by
- 15
- References
- 11
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.